Literature DB >> 7690446

Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells.

M Ziche1, L Morbidelli, A Parenti, S Amerini, H J Granger, C A Maggi.   

Abstract

The vasodilating effect of substance P (SP) at the microvascular level is endothelium-dependent. In the present study we evaluated whether SP activates nitric oxide (NO) production by venular endothelial cell. We evaluated NO activation by measuring cyclic GMP levels in cultured endothelial cells isolated from coronary postcapillary venules of bovine origin (CVEC). Our results indicate that 5 min exposure of CVEC to 10 nM SP doubled basal cyclic GMP levels. Cell treatment with the NO synthase inhibitor L-NMMA reduced the basal levels of cyclic GMP and abolished the effect of SP but did not modify the increase in cyclic GMP in response to exogenous NO. These data indicate that a) microvascular endothelium responds in an autocrine fashion to NO with increased cyclic GMP levels, b) SP activates cyclic GMP pathway through NO production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690446     DOI: 10.1016/0024-3205(93)90556-i

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Local cardiac effects of substance P: roles of acetylcholine and noradrenaline.

Authors:  H Chiao; R W Caldwell
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

2.  Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival.

Authors:  A J Kane; J E Barker; G M Mitchell; D R Theile; R Romero; A Messina; M Wagh; F O Fraulin; W A Morrison; A G Stewart
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 3.  Nitric oxide and angiogenesis.

Authors:  M Ziche; L Morbidelli
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules.

Authors:  Mack H Wu; Sarah Y Yuan; Harris J Granger
Journal:  J Physiol       Date:  2004-11-11       Impact factor: 5.182

Review 5.  Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases.

Authors:  Shyamal C Bir; Yan Xiong; Christopher G Kevil; Jincai Luo
Journal:  Cardiovasc Res       Date:  2012-04-05       Impact factor: 10.787

6.  The role of substance P in myocardial dysfunction during ischemia and reperfusion.

Authors:  H Chiao; R W Caldwell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

7.  The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium.

Authors:  H Nawrath; D Bäumner; J Rupp; H Oelert
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

8.  Protective Effects of TRPV1 Activation Against Cardiac Ischemia/ Reperfusion Injury is Blunted by Diet-Induced Obesity.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2020

9.  Nitric oxide in asthma physiopathology.

Authors:  Carla M Prado; Mílton A Martins; Iolanda F L C Tibério
Journal:  ISRN Allergy       Date:  2011-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.